PREDICTIVE FACTORS FOR RECURRENCE AND OUTCOMES IN T1A RENAL CELL CARCINOMA: ANALYSIS OF THE INMARC (INTERNATIONAL MARKER CONSORTIUM FOR RENAL CANCER) DATABASE

被引:0
|
作者
Liu, Franklin
Wang, Luke
Dhanji, Sohail
Meagher, Margaret
Afari, Jonathan
Saitta, Cesare
Ghassemzadeh, Saeed
Shah, Aastha
Puri, Dhruv
Mimi Nguyen
Hakimi, Kevin
Schmeusser, Benjamin
Greenwald, Rachel
Medline, Alexandra
Kamal, Fatima
Ali, Adil
Fukuda, Shohei
Kobayashi, Masaki
Chen, Wei
Fan, Bo
Aida, Yusuke
Maezawa, Yuya
Asai, Shintaro
Tanaka, Hajime
Patil, Dattatraya
Fujii, Yasuhisa
Master, Viraj
Derweesh, Ithaar
机构
来源
JOURNAL OF UROLOGY | 2023年 / 209卷
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
PD08-07
引用
收藏
页码:E235 / E235
页数:1
相关论文
共 50 条
  • [21] Clinicopathological Outcomes of Clinical T1a Renal Cell Carcinoma by Tumor Size
    Kitagawa, Yasuhide
    Nakashima, Kazufumi
    Shima, Takashi
    Izumi, Kouji
    Narimoto, Kazutaka
    Miwa, Sotaro
    Miyagi, Tohru
    Maeda, Yuji
    Kadono, Yoshifumi
    Konaka, Hiroyuki
    Mizokami, Atsushi
    Namiki, Mikio
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2011, 41 (05) : 637 - 641
  • [22] Risk of metastasis for T1a renal cell carcinoma
    Lee, Hakmin
    Lee, Jung Keun
    Kim, Kwangmo
    Kwak, Cheol
    Kim, Hyeon Hoe
    Byun, Seok-Soo
    Lee, Sang Eun
    Hong, Sung Kyu
    WORLD JOURNAL OF UROLOGY, 2016, 34 (04) : 553 - 559
  • [23] Risk of metastasis for T1a renal cell carcinoma
    Hakmin Lee
    Jung Keun Lee
    Kwangmo Kim
    Cheol Kwak
    Hyeon Hoe Kim
    Seok-Soo Byun
    Sang Eun Lee
    Sung Kyu Hong
    World Journal of Urology, 2016, 34 : 553 - 559
  • [24] Prognostic Significance of C-reactive Protein in Patients With Non-metastatic Papillary Renal Cell Carcinoma: Results from the INternational Marker Consortium for Renal Cancer (INMARC) Cohort
    Toide, Masahiro
    Saito, Kazutaka
    Yasuda, Yosuke
    Tanaka, Hajime
    Fukuda, Shohei
    Patil, Dattatraya
    Cotta, Brittney H.
    Patel, Sunil H.
    Master, Viraj A.
    Derweesh, Ithaar H.
    Fujii, Yasuhisa
    CLINICAL GENITOURINARY CANCER, 2022, 20 (04) : E276 - E282
  • [25] Outcomes of metastatic chromophobe renal cell carcinoma (chrRCC) in the targeted therapy era: Results from the International Metastatic Renal Cell Cancer Database Consortium
    Yip, Steven
    Morales, Jose Manuel Ruiz
    Donskov, Frede
    Fraccon, Anna Paola
    Basso, Umberto
    Rini, Brian I.
    Lee, Jae-Lyun
    Bjarnason, Georg A.
    Knox, Jennifer J.
    Beuselinck, Benoit
    Kanesvaran, Ravindran
    Brugarolas, James
    Koutsoukos, Konstantinos
    Fu, Simon Yuen Fai
    Yuasa, Takeshi
    Pezaro, Carmel Jo
    Alva, Ajjai Shivaram
    Kollmannsberger, Christian K.
    Choueiri, Toni K.
    Heng, Daniel Yick Chin
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [26] IMPACT OF PRIMARY TUMOR SIZE ON CANCER-SPECIFIC AND ALL-CAUSE MORTALITY IN PATIENTS UNDERGOING CYTOREDUCTIVE NEPHRECTOMY FOR METASTATIC RENAL CELL CARCINOMA: ANALYSIS FROM THE INTERNATIONAL MARKER CONSORTIUM FOR RENAL CANCER [INMARC]
    Nasseri, Ryan
    Master, Viraj
    Fujii, Yasuhisa
    Meagher, Margaret
    Hakimi, Kevin
    Saidian, Ava
    Patil, Dattatraya
    Saito, Kazutaka
    Derweesh, Ithaar
    JOURNAL OF UROLOGY, 2022, 207 (05): : E398 - E398
  • [27] Female Gender Predicts Favorable Prognosis in Patients With Non-metastatic Clear Cell Renal Cell Carcinoma Undergoing Curative Surgery: Results From the International Marker Consortium for Renal Cancer (INMARC)
    Fukushima, Hiroshi
    Saito, Kazutaka
    Yasuda, Yosuke
    Tanaka, Hajime
    Patil, Dattatraya
    Cotta, Brittney H.
    Patel, Sunil H.
    Master, Viraj A.
    Derweesh, Ithaar H.
    Fujii, Yasuhisa
    CLINICAL GENITOURINARY CANCER, 2020, 18 (02) : 111 - +
  • [28] Tumor necrosis is a strong predictor for recurrence in patients with pathological T1a renal cell carcinoma
    Ito, Keiichi
    Seguchi, Kenji
    Shimazaki, Hideyuki
    Takahashi, Eiji
    Tasaki, Shinsuke
    Kuroda, Kenji
    Sato, Akinori
    Asakuma, Junichi
    Horiguchi, Akio
    Asano, Tomohiko
    ONCOLOGY LETTERS, 2015, 9 (01) : 125 - 130
  • [29] Real-world outcomes of nivolumab and cabozantinib in metastatic renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium
    Stukalin, I
    Wells, J. C.
    Graham, J.
    Yuasa, T.
    Beuselinck, B.
    Kollmansberger, C.
    Ernst, D. S.
    Agarwal, N.
    Le, T.
    Donskov, F.
    Hansen, A. R.
    Bjarnason, G. A.
    Srinivas, S.
    Wood, L. A.
    Alva, A. S.
    Kanesvaran, R.
    Fu, S. Y. F.
    Davis, I. D.
    Choueiri, T. K.
    Heng, D. Y. C.
    CURRENT ONCOLOGY, 2019, 26 (02) : E175 - E179
  • [30] Real world outcomes of nivolumab and cabozantinib in metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC).
    Stukalin, Igor
    Wells, J. Connor
    Graham, Jeffrey
    Yuasa, Takeshi
    Beuselinck, Benoit
    Kollmannsberger, Christian K.
    Ernst, D. Scott
    Agarwal, Neeraj
    Le, Tri
    Donskov, Frede
    Hansen, Aaron Richard
    Bjarnason, Georg A.
    Srinivas, Sandy
    Wood, Lori
    Alva, Ajjai Shivaram
    Kanesvaran, Ravindran
    Fu, Simon Yuen Fai
    Davis, Ian D.
    Choueiri, Toni K.
    Heng, Daniel Yick Chin
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)